Pharmaceuticals
Horizon Therapeutics stock plunges on report FTC is preparing to block Amgen deal
Robert Galbraith | Reuters Horizon Therapeutics‘ stock price plunged more than 17% in premarket trading Tuesday after a report that the Federal Trade Commission is preparing to file a lawsuit to block the biotech company’s $27.8 billion sale to Amgen. The FTC could sue to block the acquisition as soon as Tuesday, Bloomberg reported, citing […]
Read More
Google Cloud launches A.I.-driven resources to accelerate drug discovery, precision medication
A particular person walks upcoming to the Google Cloud symbol at the Mobile Globe Congress (MWC) in Barcelona, Spain February 27, 2023. Nacho Doce | Reuters Google Cloud on Tuesday introduced two new AI-run instruments that intention to help biotech and pharmaceutical companies speed up drug discovery and progress precision medication. One resource, identified as […]
Read More
Americans in most states will no longer receive Covid exposure notifications on phones
Americans in most states will no longer receive Covid exposure notifications on their smartphones now that the U.S. public health emergency has ended. Since 2020, nearly 30 states have used a Bluetooth system developed by Apple and Google to track the spread of Covid infections and send push alerts to any smartphone user who came […]
Read More
Here’s why Covid vaccines will still be free for uninsured Americans as public health emergency ends
A healthcare worker prepares a dose of the Pfizer-BioNTech Covid-19 vaccine at a vaccination clinic in the Peabody Institute Library in Peabody, Massachusetts, on Wednesday, Jan. 26, 2022. Vanessa Leroy | Bloomberg | Getty Images Uninsured Americans can still access Covid-19 vaccines at no cost, for now, even though the U.S. public health emergency has […]
Read More
Pfizer CEO says Medicare will likely face legal action over drug price negotiations
Pfizer CEO Albert Bourla talks during a press conference with European Commission President after a visit to oversee the production of the Pfizer-BioNtech Covid-19 vaccine at the factory of US pharmaceutical company Pfizer, in Puurs, on April 23, 2021. John Thys | AFP | Getty Images Pfizer CEO Albert Bourla on Thursday said pharmaceutical companies […]
Read More
GOP law cut Big Pharma tax rates by 40%, Senate report says
(L-R) Richard A. Gonzalez, chairman and CEO of AbbVie Inc., Pascal Soriot, executive director and CEO of AstraZeneca, Giovanni Caforio, chairman of the board and CEO of Bristol-Myers Squibb Co., Jennifer Taubert, executive vice president and worldwide chairman of Janssen Pharmaceuticals, Johnson & Johnson, Kenneth C. Frazier, chairman and CEO of Merck & Co. Inc., […]
Read More
Eli Lilly CEO vows not to raise insulin prices again, while Novo Nordisk and Sanofi hedge
Eli Lilly CEO Dave Ricks on Wednesday promised not to raise prices on the company’s existing insulin products again — the only executive to do so before a Senate Health Committee hearing on making the life-saving diabetes drug more affordable. Sen. Bernie Sanders, the committee’s chair, asked Ricks and the CEOs of Novo Nordisk and […]
Read More
Breast cancer screenings should start at age 40 instead of 50, U.S. panel says
Medical personnel use a mammogram to examine a woman’s breast for breast cancer. Hannibal Hanschke | dpa | Picture Alliance | Getty Images Most women should get screened for breast cancer every other year starting at age 40, a decade earlier than previously recommended, according to draft guidelines issued Tuesday by a government-backed panel of […]
Read More
Novavax shares rise after company unveils positive vaccine data, plan to cut 25% of workforce
A health worker prepares a dose of the Novavax vaccine as the Dutch Health Service Organization starts with the Novavax vaccination program on March 21, 2022 in The Hague, Netherlands. Patrick Van Katwijk | Getty Images Shares of Novavax rose 5% in premarket trading Tuesday after the company unveiled promising new vaccine data and a […]
Read More
Kenvue CEO looks to brand, product innovation to drive growth after IPO
Thibaut Mongon, CEO of Kenvue Inc. a Johnson & Johnson consumer-health business, speaks during an interview with CNBC during his company’s IPO at the New York Stock Exchange (NYSE), May 4, 2023. Brendan McDermid | Reuters Kenvue CEO Thibaut Mongon is betting on brand and product innovation to drive growth at the newly spun-out company […]
Read More